ENTITY
Abbvie Inc

Abbvie Inc (ABBV US)

187
Analysis
Health Care • United States
AbbVie Inc. researches and develops pharmaceutical products. The Company produces pharmaceutical drugs for specialty therapeutic areas such as immunology, chronic kidney disease, Hepatitis C, women's health, oncology, and neuroscience. AbbVie also offers treatments for diseases including Multiple Sclerosis, Parkinson's, and Alzheimer's disease.
more
bullish•Abbvie Inc
•23 Sep 2025 10:44

Primer: AbbVie (ABBV UN) - Sep 2025

AbbVie is successfully navigating the loss of exclusivity for its former blockbuster drug, Humira, driven by the robust growth of its...

Logo
84 Views
Share
x